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Key points
 A- and C-nociceptors make different contributions to pain. They signal fast and slow pain,
respectively, and C-nociceptors drive central sensitisation.
Cyclooxygenase-1 (COX-1)-dependent descending facilitation from the periaqueductal grey
(PAG) affects C-nociceptor spinal reflexes, but leaves A-nociceptor reflexes largely untouched.
 We studied the responses of spinal wide dynamic-range dorsal horn neurons to A- and
C-nociceptor stimulation before and after COX-1 inhibition in the PAG.
 Inhibition of COX-1 descending facilitation disrupted the neuronal encoding of C-nociceptor
information, but left the encoding of A-nociceptor information untouched.
 Inhibition of COX-1-dependent descending facilitation increased the activation threshold of
wide dynamic range neurons to both A- and C-nociceptor input.
 The COX-dependent descending system from the PAG can therefore control the amount of
C-nociceptor information reaching the CNS (slow, burning, aching, debilitating pain) without
affecting the protective A-nociceptor information (sharp, well-localised, protective pain).
Abstract The experience of pain is strongly affected by descending control systems originating in
the brainstem ventrolateral periaqueductal grey (VL-PAG), which control the spinal processing
of nociceptive information. A- and C-fibre nociceptors detect noxious stimulation, and have
distinct and independent contributions to both the perception of pain quality (fast and
slow pain, respectively) and the development of chronic pain. Evidence suggests a separation
in the central processing of information arising from A- vs. C-nociceptors; for example,
inhibition of the cyclooxygenase-1 (COX-1)–prostaglandin system within the VL-PAG alters
spinal nociceptive reflexes evoked by C-nociceptor input in vivo via descending pathways, leaving
A-nociceptor-evoked reflexes largely unaffected. As the spinal neuronal mechanisms under-
lying these different responses remain unknown, we determined the effect of inhibition of
VL-PAG COX-1 on dorsal horn wide dynamic-range neurons evoked by C- vs. A-nociceptor
activation. Inhibition of VL-PAG COX-1 in anaesthetised rats increased firing thresholds of
lamina IV–V wide dynamic-range dorsal horn neurons in response to both A- and C-nociceptor
stimulation. Importantly,widedynamic-rangedorsal hornneurons continued to faithfully encode
A-nociceptive information, even after VL-PAG COX-1 inhibition, whereas the encoding of
C-nociceptor information by wide dynamic-range spinal neurons was significantly disrupted.
Dorsal horn neurons with stronger C-nociceptor input were affected by COX-1 inhibition to a
greater extent than those with weak C-fibre input. These data show that the gain and contrast of
C-nociceptive information processed in individual wide dynamic-range dorsal horn neurons is
modulated by prostanergic descending control mechanisms in the VL-PAG.
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Introduction
Descending control from the periaqueductal grey
(PAG) dynamically modulates spinal nociceptive
processing as part of coordinated behavioural responses
(Bandler et al. 2000; Lovick & Bandler, 2005). Although
descending control systems from PAG were considered
to be solely inhibitory, it is now clear that facilitatory
influences can also be evoked from the PAG (Heinricher
et al. 2004; Martins et al. 2010; Chu et al. 2012).
The balance of descending inhibition and facilitation is
critical in determining the output from the dorsal horn,
and the resultant sensory, autonomic and behavioural
consequences of nociceptive input (Lovick & Bandler,
2005; Heinricher et al. 2009).
Descending controls from the PAG discriminate
between information originating from A- and C-fibre
nociceptors, preferentially controlling C-fibre-evoked
nociceptive processing (Waters & Lumb, 1997;
McMullan & Lumb, 2006a,b; Koutsikou et al. 2007).
Cyclooxygenase-1 (COX-1) inhibitor and prostaglandin
administration into the ventrolateral (VL-) PAG pre-
ferentially inhibit or facilitate C-fibre-evoked withdrawal
reflexes, respectively (Leith et al. 2007).
The acute pain experience evoked by C-nociceptor
activation is very different from A-nociceptor activation
(slow, burning, poorly localised vs. sharp, well localised
(Ochoa & Torebjork, 1989; Magerl et al. 2001)). The
nociceptor sub-types also play distinct roles in chronic
pain states (Fuchs et al. 2000;Magerl et al. 2001). Increased
C-nociceptor activity, associated with tissue damage,
initiates andmaintains central sensitisation, which under-
pins the cardinal signs of chronic pain, such as secondary
hyperalgesia and allodynia. Importantly, C-nociceptor
drive is necessary for spinal sensitisation to A-fibre inputs
(Treede & Magerl, 2000; You et al. 2010). The preferential
modulation of C-nociceptive input by the PAG therefore
has important functional consequences. It is now apparent
that pathological alterations in descending control systems
also contribute to the development and maintenance of
chronic pain states (Vanegas & Schaible, 2004; Pertovaara,
2006; Saade & Jabbur, 2008).
TheCOX–prostaglandin systemwithin thePAGplays an
important role in regulating spinal nociceptive processing.
COX-1,COX-2 and receptors for prostaglandinE2 (PGE2)
are expressed in the PAG (Breder et al. 1992, 1995;
Matsumura et al. 1992; Ek et al. 2000; Nakamura et al.
2000). Prostaglandins or synthetic analogues inhibit
glutamatergic (Lu et al. 2007) and potentiate GABAergic
and glycinergic transmission in the PAG (Vaughan, 1998;
Shin et al. 2003). In vivo, PAG COX-1 facilitates spinal
nociceptive withdrawal reflexes (Leith et al. 2007), and
microinjection of PGE2 into VL-PAG produces hyper-
algesia (Heinricher et al. 2004; Oliva et al. 2006; Leith
et al. 2007). Functional PGE2 receptors in the PAG
facilitate both acute chemical and chronic neuropathic
pain (Oliva et al. 2006; Palazzo et al. 2011). Although
administration of non-specific COX inhibitors into the
PAG alters dorsal horn neuronal activity (Carlsson et al.
1986; Carlsson & Jurna, 1987; Vanegas et al. 1997;
Hernandez & Vanegas, 2001), the mechanisms through
which the COX-1-dependent facilitatory system from
PAG to spinal cord modulates spinal sensory processing
remain largely unknown. We therefore determined the
actions of the descending control pathways regulated
by COX-1 activity in the (VL)-PAG on their sensory
neuronal targets in the spinal dorsal horn, to provide
further insights into the neuronal mechanisms under-
lying differential control of A- and C-fibre-evoked spinal
nociception. A novel aspect of the study was to quantify,
and then relate, the degree of descending tonic facilitation
to the magnitude of C-fibre drive to dorsal horn neurons.
C-nociceptors have a key function in the establishment of
central sensitisation, generating central neuronal changes
underpinning the establishment of chronic pain states
(Stemkowski & Smith, 2012). A-nociceptors signal acute
pain and serve a protective function under normal
conditions (Cervero, 2009), whereas C-nociceptor-driven
central sensitisation facilitates processing of A-nociceptor
inputs in pain states (Magerl et al. 2001). Given these
distinct roles of A- and C-nociceptors in physiological and
pathophysiological nociceptive processing, understanding
the dorsal horn neuronal mechanisms underlying the pre-
ferential control of these different functional spinal inputs
is highly clinically relevant.
Methods
All experiments were carried out in accordance with
the UK Animals (Scientific Procedures) Act, 1986 and
associated guidelines, and with approval of the Ethical
Review Groups of the University of Bristol and GSK. A
total of 46 male adult Wistar rats (280–320 g) were used
in these experiments. Animals were housed in standard
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conditions and handled frequently to minimise stress on
the day of the experiment.
Animal preparation – behavioural study
Twenty rats were used in these experiments. Animals were
anaesthetised with 2–4% isofluorane in oxygen. The head
was secured in a stereotaxic frame and a stainless steel
intracerebral guide cannula (26 gauge, cannula cut 8 mm
below the pedestal; PlasticsOne, Voanoke, VA, USA) was
implanted in the left VL-PAG (coordinates relative to
Bregma 7.4–7.5 caudal, 0.9 mm left of midline, 6.5 mm
below skull surface) and secured to the skull with screws
and cyanoacrylate (RS Components, Corby, UK). A stylet
was secured in the cannula to maintain patency. Animals
received antibiotic cover, 1ml kg−1 Synulox S.C. (clavulanic
acid 35mgml−1 and amoxycillin 140mgml−1, PfizerUK),
and analgesia, 0.4 ml Rimadyl S.C. (carprofen 50mgml−1)
during surgery. Following a recovery period of at least
5 days, three baseline paw withdrawal thresholds to a
thermal ramp stimulus were measured (22–50°C ramp at
1°Cs−1 deliveredusing aPeltier device to the left hindpaw;
equipment built in-house). The temperature at which the
paw was withdrawn from the thermal stimulus was taken
as the end point. A minimum of 30 min was left between
repeated thermal stimuli on the same animal.
Animals were assigned randomly to one of two
experimental groups (each n = 10) for drug adminis-
tration. Compounds were administered via the implanted
guide cannula, vehicle (300nl 30%DMSO inphysiological
saline) or ketoprofen (COX inhibitor; 10 μg in 300 nl)
as used previously in terminally anaesthetised animals
(Leith et al. 2007). The experimenter was blinded to the
identity of the drug administered during the testing phase.
Compounds were injected into the PAG using an internal
‘injector’ guide cannula cut to project 0.5 mm beyond
the end of the implanted guide cannula (PlasticsOne)
connected to a 1 μl syringe (Scientific Glass Engineering,
Ringwood, Vic., Australia). Animals were held securely
and the stylet removed from the implanted guide cannula.
Compounds were injected over 1 min and the injector
was left in place for an additional minute after the
completion of the injection to prevent backflow of the
compound up the cannula. The stylet was then replaced
into the implanted cannula. Paw withdrawal thresholds
to the thermal ramp device were tested again 30 min
after drug administration. At the end of the behavioural
experiments, animals were killed by a rising concentration
of carbon dioxide. Brains were removed and fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer for at least
24 h, then cryoprotected in 30% sucrose solution for at
least 24 h, before sectioning at 60 μm. PAG injection
sites were localised with reference to a rat brain atlas
(Paxinos & Watson, 2006). Animals in which the cannula
was found tohavebeenoutwith theVL-PAGwere excluded
from further analysis. As a result of post hoc injection site
analysis, two animals were removed from the ketoprofen
group, and four from the vehicle group in the behavioural
experiments.
Animal preparation terminal experiments
Twenty-six rats were used in these experiments.
Anaesthesia was induced using 4% halothane in O2
delivered through a mask over the snout, and a branch
of the external jugular vein was cannulated for anaesthetic
maintenance. A branch of the carotid artery was exposed
and cannulated for recording of blood pressure. Body
temperature was maintained within physiological limits
by means of a feedback-controlled heating blanket and
rectal probe. A laminectomy was carried out between T11
and T13 to record from lumbar dorsal horn neurons.
Animals were then positioned in a stereotaxic frame and a
craniotomy was performed, to allow micropipette access
to the PAG. Following surgery, anaesthesiawasmaintained
using a constant I.V. infusion of alphadolone/alphaxalone
(20 mg kg−1 h−1; Saffan, Schering Plough Animal
Health, UK) at a level at which there were no precipitous
changes in blood pressure to minor noxious stimuli.
Preferential activation of A- or C-nociceptors
A- or C-heat nociceptors were stimulated using a custom
made heating lamp system to deliver fast or slow rates
of skin heating respectively to the dorsal surface of the
hindpaw, as described previously (McMullan et al. 2004;
Leith et al. 2007). In brief, heat from a sputter-coated
projector bulb was focused onto a blackened copper disc
positioned at the focal point. A T-type thermocouple
(made in-house: 0.02 mm diameter copper/constantin)
was fixed to the outer surface of the copper plate which
measured the surface temperature of the skin when placed
in firm, even contact with the hindpaw dorsum. Using
a constant bulb voltage, fast rates of heating (contact
heating rate 7.5 ± 1°C s−1) were used to preferentially
activate A-fibre (myelinated, capsaicin-insensitive) heat
nociceptors, whereas slow rates of heating (contact
heating rate 2.5 ± 1°C s−1) were used to preferentially
activate C-fibre (unmyelinated, capsaicin-sensitive) heat
nociceptors. Our previous studies (McMullan et al. 2004)
demonstrate that these heating rates measured at the skin
surface reliably reproduce the same subcutaneous heating
rates as thosepreviouslydescribed topreferentially activate
A- vs. C-nociceptors (Yeomans et al. 1996; Yeomans
& Proudfit, 1996), and that they are not adversely affected
by alterations in local blood flow resulting from mild
inflammation (Drake et al. 2014). The cut-off temperature
of the heat lamp was controlled via a Spike2 script to pre-
vent tissue damage. Fast or slow heat ramps were carried
out at 8 min intervals to avoid sensitisation (McMullan
et al. 2004).
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Recording of dorsal horn neuronal activity
The vertebral column was clamped at each end of
the laminectomy to maximise the stability of the pre-
paration. The dura was removed, a pool was made
with skin flaps and the whole area was filled with
agar to further stabilise the preparation. Once set, a
small window was cut out of the agar over the desired
recording site and filled with warm paraffin oil. A
glass-coated tungsten microelectrode (5 M; Merrill
& Ainsworth, 1972) was lowered into the cord at the
rostrocaudal location at which maximum field potentials
had been observed to low intensity percutaneous electrical
stimulation of the hairy skin of the contralateral hindpaw.
Single-unit neuronal activity was amplified (×5000) and
filtered (500 Hz–10 KHz; Neurolog system) before being
captured for subsequent analysis via a 1401plus (CED,
Cambridge, UK) onto a PC running Spike2 v5 software
(CED).
Functional classification of spinal neurons
Wide dynamic-range (WDR; class 2) cells in the deep
dorsal horn were located using low threshold search
stimuli (gentle tapping or brushing) delivered to the
ipsilateral (left) hindpaw. Responsive cells were then tested
with high threshold, noxious stimuli (firm pinch with
untoothed forceps, and fast and slow heat ramps, to pre-
ferentially activate A- or C-heat nociceptors, respectively,
as above). Only cells that responded to both low and
high threshold stimuli (including heat) were characterised
further, corresponding to the class 2 neurons described
previously (Menetrey et al. 1977, 1979). Once a suitable
cell was located, its excitatory receptive field (ERF) was
mapped using both low and high threshold stimuli (brush
and firm pinch, respectively). Only cells that had ERFs
located on the dorsal surface of the left hindpaw that were
both accessible to, and larger than, the copper disc of
the heating lamp were included in this study. It was not
possible to investigate the responses of class 3 neurons
in this study as a low threshold search stimulus was
used. Prolongeduse of high intensity electrical stimulation
that would be necessary to locate class 3 units (Light
et al. 1986) was considered unsuitable due to the risc
of high intensity stimuli evoking changes in normal
somatosensoryprocessing.Deepdorsal hornneuronswere
studied here because although superficial (e.g. lamina I)
neurons are also important in theprocessingofnociceptive
inputs, deep dorsal horn neurons integrate A- and
C-nociceptive inputs, enabling study of responses to both
nociceptor types, and in general give larger responses to
nociceptive inputs than lamina I neurons (Seagrove et al.
2004).
Neuronal activity of class 2 neurons was recorded
continuously at 103 samples s−1 using Spike2 software.
A ‘wavemark’ template was created so that all matching
spikes fromthe samecellwerewritten to a separate channel
at 20,000 samples s−1. This channel was duplicated and
displayed both as the waveform of each event and as firing
frequency, fromwhich the rate of spontaneous activity and
the responses of the cell to peripheral stimuli could then
be measured.
Previous work from this laboratory suggests that the
effects of PAG modulation on noxious pinch-evoked
activity in dorsal horn neurons might be related to the
profile of afferent input to the neuron under study (Waters
&Lumb, 2008). Therefore, the afferent input to the cell was
characterised by percutaneous electrical stimulation at the
centre of the ERF, i.e. the site at which the largest response
was evoked (as determined by responses to high and low
intensity stimuli as described above) via needle electrodes
placed 5 mm apart and delivering constant voltage square
pulses at 0.1 Hz, 1 ms duration (DS2 isolated stimulator;
Digitimer,WelwynGardenCity,UK). Electrical thresholds
for activation of A- and C-fibres were determined by the
appearance of a short (<20 ms) and long (90–350 ms;
Urch & Dickenson, 2003) latency response, respectively.
Cells that responded with one or more spikes at C-fibre
latency were classified as C+ve (Waters & Lumb, 2008).
To quantify C-fibre-evoked activity, repeated electrical
stimuli were delivered at both 1.5 and 3 times C-fibre
threshold voltage in most cases. In four cells, repeated
sweeps were made only at 1.5 times C-fibre threshold and
in four cells only at 3 times C-fibre threshold. Peristimulus
time histograms and/or raster plots were constructed from
20 sweeps at 1.5 and 3 times C-fibre threshold, and the
response (mean spikes per sweep) of each cell at C-fibre
latency was determined.
Responses to slow and fast heat ramps were quantified
by dividing the total spike number by the ramp length
(giving spikes s−1) and corrected for spontaneous activity
(SA). SA was measured over a 10 s period prior to ramp
onset excluding theperiod immediately prior to each ramp
as removal of a foil barrier in the lamp apparatus at the
start of each ramp sometimes elicited a shortmechanically
evoked burst of firing in some cells. Correlations of
response to slow ramps vs. spikes at C-fibre latency were
made for both 1.5 and 3 times C-fibre threshold. The
population of cells included in this study is the same as
that previously presented (see Fig. 2; Leith et al. 2007),
in which some of the peripheral characteristics of the
population were characterised. These data are, however,
not re-presented here.
Experimental protocol
The effect of administration of the COX-1 inhibitor
SC-560 or its vehicle (PBS, Sigma, Poole UK) into the
VL-PAG was tested in 18 of the 27 cells, on neuronal
responses to fast and slow heat ramps applied to the centre
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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of the ERF. The data from the nine other cells had been
previously collected from naı¨ve animals (n = 9) that
were used to generate baseline data on spinal dorsal horn
responses evoked by fast and slow heat ramps. The effect
of injection of drug or vehicle on responses to both fast
and slow heat ramps in individual animals was tested in 12
cells (6 with SC-560, 6 with vehicle). In these experiments,
fast and slow heat rampswere alternated over the course of
the experiment. In one of the 6 vehicle cells, it was possible
to make a second injection and the effects of SC-560 on
slow heat ramps were also tested. In the remaining cells,
the effect of SC-560 on either fast (n = 4) or slow (n = 2)
heat ramps was determined. Thus, in the 18 cells, in a
subset of 12 animals, 9 cells were treated with SC-560 and
tested with slow ramps, and 10 were treated with SC-560
and tested with fast ramps. The remaining six animals
were treated with vehicle and both fast and slow ramps.
For analysis, in the cells tested with both fast and slow
ramp responses, each was treated as an independent data
point.
Once reproducible baseline values of neuronal
responses to fast or slow heat ramps were achieved, a
glassmicropipette containing drug (SC-560, 300nl, 50 nM;
Smith et al. 1998; Leith et al. 2007) or vehicle (0.0005%
DMSO in saline) solution was lowered vertically into the
VL-PAG contralateral to the stimulated hindpaw.
Glass micropipettes contained SC-560 or vehicle plus
5% Pontamine Sky Blue dye to mark injection sites.
Final drug doses used were based on effective doses as
described and previously used (Smith et al. 1998; Leith
et al. 2007). Solutions were pressure ejected from the
micropipette over 1min (starting at t= 0min as illustrated
in the graphs). Fast or slow heat ramps were resumed at
1 min and neuronal activity was recorded for a further
65 min.
The depth of neuronal recordings was measured from
the surface of the spinal cord using a calibrated depth
display on the stepping micro-drive used to position
the electrode for recording, and visually verified at the
correct depth using Pontamine Sky Blue injections at the
surface, and 500 μm and 1500 μm at the end of an
experiment.
Data analysis
Quantification of electrically evoked afferent input and of
responses to fast and slow heat ramps was carried out as
described above. Neuronal responses to fast and slow heat
ramps were then analysed in greater detail with respect
to the firing threshold and suprathreshold activity as
reported previously (McMullan & Lumb, 2006b). In brief,
because many cells exhibited some level of SA, threshold
was defined as the temperature at which firing exceeded
SA (by 2 SD) and remained elevated above SA throughout
the remainder of the ramp.
Effects of SC-560 or vehicle administration into the
VL-PAG on dorsal horn neuronal responses to fast
and slow heat ramps
For each cell, both the peak change in threshold
post-SC-560 or vehicle (the time point at which the firing
threshold post-SC-560 or vehicle was most altered (either
positively or negatively) from control) and the overall
effect over time on thresholds was measured (the area
under the curve (AUC) of the graph of threshold against
time, over the period 0–65min after drug administration).
The ability of dorsal horn neurons to encode
temperature changes during heat ramps in their firing
patterns was also analysed, as previously described
(McMullan & Lumb, 2006b). Temperature encoding was
calculated for control (pre-SC-560) responses and also
at the time point post-SC-560 at which the activity of
each cell was most altered (peak positive or negative)
from control. Briefly, a Spike2 script (written by S. Gray,
CED) generated bins for every 1°C above threshold
and calculated spike counts for each bin (spikes °C−1
per bin) and the width of each bin (s). Spikes °C−1 per bin
was corrected for bin width giving spikes s−1 °C−1, then
corrected for SA. Three control data sets from each neuron
were averaged and the mean data set normalised against
the first bin of the response (i.e. [bin X response bin 1
response] × 100% = normalised response; therefore, first
bin of response = 100%). For post-SC-560 responses, the
raw data set was normalised against the first bin of the
baseline response.
At the end of experiments, animals were killed by
an overdose of sodium pentobarbital (30 mg I.V. bolus;
Sigma) and injection sites were localised as detailed for
the behavioural experiments above. None of the animals
in terminal experiments was excluded after injection site
analysis.
Statistical analyses
For statistical comparison of outcome measures using
Graphpad Prism versions 4–6, normally distributed data
with equal variance were compared using Student’s t-tests
(two groups, paired or unpaired as appropriate, e.g.
Fig. 2) or one-way ANOVA (three or more groups,
e.g. Fig. 1) as detailed in the text. If the data did not
meet the assumptions of parametric tests (non-Gaussian,
unequal variances), then non-parametric test equivalents
were used, as stated in the text and figure legends.
Correlations were tested using Spearman’s correlation
analysis. Encoding functions were generated by regression
analyses of the data (linear or non-linear). Curves were
fit using a least squares fit. Comparison of whether linear
or Gaussian fits best fit the data sets, or whether a single
curve (either linear or Gaussian) fit both data sets before
and after PAG drug or vehicle delivery was made using
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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an extra-sum-of-squares F test in Prism 6. Effects of
drug compared to vehicle over time were compared using
two-way ANOVA, with the assumptions associated with
Gaussian distributions.
Results
Are descending prostanergic facilitatory controls
tonically active or evoked by experimental surgery?
We and others have previously shown a descending
prostanergic facilitation on spinal nociceptive processing
in anaesthetised animals, which has been proposed to
exert a tonic influence (Heinricher et al. 2004; Leith et al.
2007). It is possible that these facilitatory influences could
be induced by the experimental surgery, and might not
be present in the normal animal (Vanegas & Schaible,
2004). To exclude this possibility, and to aid in the inter-
pretation of data on descending modulation of dorsal
horn neuronal responses, we first determined whether
tonic COX-dependent facilitation was apparent in awake
naı¨ve rats, as well as in anaesthetised rats. Injection of the
non-selective COX inhibitor ketoprofen into PAG resulted
in a significant increase in thermal withdrawal threshold
not found with vehicle injection (Fig. 1; Kruskal–Wallis
statistic 18.45, P = 0.0004), showing that there was
demonstrable descending prostanergic facilitation in the
absence of anaesthesia. These experiments were designed
to provide proof of concept (i.e. that there was a
COX-dependent mechanism that was not activated by
surgical procedures) and, as such, a non-selective COX
inhibitor was used. Once established, the dorsal horn
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Figure 1. The effect on thermal paw withdrawal thresholds of
acute administration of the COX inhibitor ketoprofen into the
PAG, in the awake animal
Data are shown as individual points, lines are medians and
interquartile ranges before (filled) and after (white/crosshatched)
ketoprofen (n = 8) or vehicle (n = 6) administration into the PAG
(Kruskal–Wallis statistic = 18.45, P = 0.0004 followed by post hoc
Dunn’s tests, ∗∗P < 0.01, compared to both before ketoprofen and
after vehicle).
studies used a COX-1 antagonist based on previous
findings (Leith et al. 2007).
Responses of neurons to peripheral stimuli
Recordings were made from 27 deep dorsal horn neurons
from 26 rats, with a mean depth of 779 ± 31 μm from
the cord surface (Table 1), to characterise responses to
peripheral heat ramps. All neurons responded to both
innocuous and noxious stimuli (summarised in Table 1),
and were therefore WDR or class 2 neurons (Menetrey
et al. 1977, 1979). All neurons had ERFs located on the
dorsal surface of the left hindpaw, with some extending
into the toe region and/or into the lateral plantar surface,
and typically covering an area equivalent to one-quarter
of the dorsal surface of the hindpaw.
Control responses to fast and slow heat ramps, which
preferentially activate A- and C-fibre heat nociceptors,
respectively, were examined in all 27 neurons. The degree
of C-nociceptor input and its relationship with the neuro-
nal response to slow ramp heat stimulation have been
previously reported (Leith et al. 2007). A-nociceptor
activation evoked responses over the entire duration of
the ramp (mean 24.7 ± 2.3 spikes s−1), with a mean
firing threshold of 44.8 ± 0.5°C and a mean supra-
threshold firing rate of 40.0 ± 2.3 spikes s−1. Responses
to C-nociceptor activation were variable, with some cells
responding very vigorously, others only very weakly and
one cell did not respond at all, consistent with a variable
degree of C-nociceptor input to dorsal horn neurons
(Waters & Lumb, 2008). C-nociceptor activation also
evoked responses over the entire duration of the ramp
(mean 14.3 ± 2.0 spikes s−1, n = 27, 15.0 ± 2.0 spikes s−1
(n = 26, excluding the cell that did not respond)), with a
mean firing threshold of 42.6 ± 0.8°C and a mean supra-
thresholdfiring rate of 21.8± 1.4 spikes s−1 (Table 1). Both
the suprathreshold firing rates (t26 = 4.82, P < 0.0001,
n = 27 per group) and the response thresholds were
significantly higher in response to A-nociceptor compared
to C-nociceptor activation (t25 = 2.97, P= 0.0065, n= 27
(A-nociceptors) and 26 (C-nociceptors, as one cell did not
respond to C-input (C-ve)) (Fig. 2).
All neurons responded to electrical stimulation
of their ERFs with a short latency (<20 ms,
A-nociceptor-mediated response (mean threshold of
1.7 ± 0.1 V)), and in 26/27 neurons a long
latency (90–350 ms) C-fibre-mediated response was also
observed at higher stimulus intensities (mean threshold
11.1 ± 0.9 V). Stimulus intensities required to evoke
activity at C-fibre latency were always significantly higher
than those required to evoke activity at A-fibre latency
(P < 0.001, Wilcoxon signed rank test), suggesting that
the long latency responses observed were indeed due to
C-fibre activation rather than A-fibre activation via a
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Table 1. Summary of characteristics and response properties of recorded units
Parameter Mean ± SEM Median Range
Depth (μm) 779 ± 31 760 510–1170
Spontaneous activity (spikes s−1) 2.9 ± 0.5 2.0 0–15.0
Thermal stimulation
A-nociceptor activation Overall response (spikes per ramp s−1) 24.7 ± 2.3 24.1 4.5–56.2
Firing threshold (°C) 44.8 ± 0.5 44.6 38.0–50.4
Suprathreshold activity (spikes s−1) 40.0 ± 2.3 39.7 13.4–78.2
C-nociceptor activation Overall response (spikes per ramp s−1) 14.3 ± 2.0 10.9 0.4–34.1
Firing threshold (°C) 42.6 ± 0.8 41.7 36.9–52.5
Suprathreshold activity (spikes s−1) 21.8 ± 1.4 21.3 3.8–38.3
Electrical stimulation A-fibre threshold (V) 1.7 ± 0.1 2.0 0.5–3.0
C-fibre threshold (C+ve cells only, n = 26; V) 11.1 ± 0.9 10.5 6.0–25.0
Spikes at C-fibre latency at 1.5 T (C+ve cells only, n = 26) 4.6 ± 0.6 3.7 0.9–10.9
Spikes at C-fibre latency at 3 T (C+ve cells only, n = 26) 6.7 ± 0.8 4.9 2.1–15.1
The data show the depth of neurons (n = 27) from the cord surface, level of spontaneous activity and response properties to electrical
and thermal stimulation of recorded units.
polysynaptic relay. The magnitude of C-fibre drive to cells
was quantified; in the 26C+ve neurons, themean number
of spikes evoked at C-fibre latency at 1.5 times C-fibre
threshold was 4.6 ± 0.6, and was significantly greater at
3 times C-fibre threshold (6.7 ± 0.8 spikes; P = 0.0003,
Wilcoxon signed rank test). In the C-ve cell, no spikes were
evoked at C-fibre latency, even at stimulus intensities up
to 90 V (Waters & Lumb, 2008). This cell gave no clear
response to slow heat ramp stimulation, but did give a
clear and robust response to fast heat ramps.
Based on the number of electrically evoked action
potentials at C-fibre latency in cells in this study, a
spectrum of C-fibre drive was observed, with some cells
responding vigorously to C-fibre stimulation (‘strong’
C+ves), others responding less vigorously (‘weak’ C+ves)
and one cell not responding (C-ve). We have pre-
viously reported data from these cells showing that those
that responded most robustly to slow heat ramps had
more vigorous firing to electrically evoked C-fibre input,
whereas those that responded only weakly to slow heat
ramps in general had relatively weak electrically evoked
C-fibre input (see Fig. 2; Leith et al. 2007). There is a highly
significant positive correlation between the electrically
evoked C-fibre activity and the overall response to slow
heat ramps at both 1.5 and 3 times C-fibre threshold in
individual WDR neurons (Leith et al. 2007).
COX-1 inhibition by SC-560 in the VL-PAG increases
firing thresholds of dorsal horn neurons to both A-
and C-nociceptor activation
As noxious withdrawal reflexes to C-nociceptor
stimulation were affected by PAG COX-1 inhibition
(Leith et al. 2007), we determined the effects of the
COX-1 inhibitor SC-560or vehicle administration into the
VL-PAGondorsal hornneuronal responses in the 18C+ve
cells (Figs 3 and 4). SC-560 increased thresholds to both
C-nociceptor (Fig. 3A and B; two-way between-factors
ANOVA: effect of drug F1,134 = 76.8, P < 0.0001; effect
of time F9,134 = 2.1, P = 0.04; interaction F9,134 = 2.9,
P = 0.004) and A-nociceptor activation (Fig. 3C and
D; two-way between-factors ANOVA: effect of drug
F1,144 = 91.6, P < 0.0001; effect of time F9,144 = 2.2,
P = 0.02; interaction F9,144 = 3.8, P = 0.0003). The
effect of SC-560 on C-nociceptor peak responses was
significantly greater than the effect of vehicle (Fig. 4A)
whereas the overall change was significantly greater than
vehicle for both A- and C-nociceptor stimulation. The
increase in peak threshold caused by SC-560 injection
(A-nociceptor: baseline: 44.1 ± 0.9°C; peak 48.1 ± 0.9°C
at 57 min: C-nociceptor: baseline: 42.2 ± 1.3°C; peak
46.4 ± 1.1°C at 65 min; one-way ANOVA F3,27 = 10.90,
P < 0.0001; Fig. 4A and B)) and the change in over-
all threshold over time by SC-560 (measured as AUC;
A-nociceptor: 186.7 ± 25.3 min·°C vs. C-nociceptor:
211.2 ± 35.9 min·°C, one-way ANOVA F3,27 = 3.97,
P = 0.018) were similar for A- and C-nociceptor
stimulation. Vehicle alone had no significant effect on
firing thresholds compared to control responses.
Given that we previously described a mean inhibition
of noxious pinch-evoked responses in C+ve neurons, but
amean facilitation of C-ve neurons following non-specific
neuronal activation of the PAG (Waters & Lumb, 2008),
we hypothesised that the overall magnitude of inhibition
(raised threshold) of C+ve neurons evoked by COX-1
inhibition might also be related to the profile of their
afferent drives, in particular to the level of C-fibre drive.
There was a significant positive correlation between the
magnitude of change in both peak and overall change in
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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threshold with time (AUC) in response to SC-560 and
the magnitude of C-fibre drive at both 3 times threshold
stimulation (Fig. 4B and D filled symbols; threshold
change, r = 0.6, n = 14, P = 0.009; overall (AUC)
inhibition, r = 0.7, n = 14, P = 0.007; note that in
three cells treated with drug, electrically evoked activity
at 3 times threshold was not determined, and these are
therefore not included), and 1.5 times threshold (data not
shown). These data indicate that those cells with greater
C-fibre drive were indeed subject to greater descending
control from the PAG. Neither variable correlated with
the response to vehicle (Fig. 4B and D, open symbols:
threshold change, r= 0.04, n= 10, P= 0.9; overall change
in threshold with time, r = 0.12, n = 10, P = 0.7).
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Figure 2. Responses of dorsal horn neurons to thermal
activation of A- and C-nociceptors are significantly different
A, the magnitude of overall responses of class 2 deep dorsal horn
neurons to activation of A-fibre nociceptors was greater than that to
activation of C-fibre nociceptors. B, thermal thresholds for
A-nociceptor activation were significantly higher than for
C-nociceptor activation. ∗∗∗P = 0.0065, ∗∗∗∗P < 0.0001, paired
Student’s t test.
Encoding of C-fibre information is lost, whereas
encoding of A-fibre information remains intact
following COX-1 inhibition in the VL-PAG
Neuronal activity evoked by A-nociceptor activation
increased linearly with increased skin temperature above
threshold and was best modelled by a linear regression
line (Fig. 5A; slope 3.61 ± 0.36 spikes s−1·°C, y-axis
intercept 21.0 ± 2.4 spikes s−1). There was a positive
correlation between A-nociceptor-evoked activity and
contact skin temperature (r = 0.99, P < 0.0001,
Spearman’s rank correlation). In contrast, neuronal
activity evoked by C-nociceptor activation increased
linearly with temperature over approximately the first
5°C above threshold, then reached a plateau and
subsequently decreased as skin temperature increased
further.
There was a significant difference between A- and
C-nociceptor encoding functionswhen linear vs.Gaussian
fits were compared (A-nociceptors – linear (F1,164 = 2.52,
P = 0.11) vs. C-nociceptors – Gaussian (F1,138 = 6.8,
P = 0.009)), i.e. the A- and C-nociceptor response
functions could not be fit by the same linear function.
C-nociceptor-evoked activity was better modelled by
a Gaussian distribution (r2 = 0.22) than by linear
regression (r2 = 0.13). In C-nociceptors, evoked activity
did not correlate significantly with temperature (r= 0.43,
P = 0.10; Spearman’s rank correlation). A-nociceptor
activation generally evoked higher rates of dorsal
horn neuronal activity at any given temperature than
C-nociceptor activation (Fig. 5A). Comparison of the lines
of best fit for the encoding functions showed that linear
temperature encoding of A-nociceptor-evoked activity
remained unaltered after administration of SC-560 into
the PAG (Fig. 5B: F2,242 = 1.16, P = 0.32). However, the
Gaussian temperature encoding of C-nociceptor-evoked
activity was significantly reduced by intra-PAG SC-560
injection (Fig. 5C; F3,211 = 31.7, P < 0.0001).
Magnitude of SC-560 inhibition of noxious neuronal
responses is independent of PAG injection site
A possible explanation for variability in the magnitude of
descending control is the difference in the injection sites
within the VL-PAG between experiments. To investigate
whether the level of descending inhibition was related to
injection site within the PAG, the rostrocaudal coordinates
of each site were plotted against the overall inhibition of
neuronal firing threshold (Fig. 6). There was no obvious
relationship between the level of descending inhibition
and injection site (for A- and C-nociceptor activation
combined: r= 0.05, P= 0.82, n= 21; A-nociceptor alone:
r = 0.04, n = 11, P = 0.96; C-nociceptor alone: r = 0.19,
n = 10, P = 0.59; Spearman’s correlation).
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Discussion
A- and C-fibre nociceptors have distinct and independent
contributions to the perception of pain quality,
and the development of chronic pain, as increased
C-nociceptor drive after damage sensitises spinal circuits
to A-nociceptor inputs (Treede & Magerl, 2000; You
et al. 2010). There is evidence to suggest a separation
in the central processing of information arising from
A- vs. C-nociceptors, including differential descending
modulation (McMullan & Lumb, 2006a,b; Koutsikou
et al. 2007; Leith et al. 2007; You et al. 2010). However,
the mechanisms underlying this differential modulation
remain unknown.We demonstrate the presence of a tonic
COX-dependent descending control system on spinal
nociceptive processing from VL-PAG present in awake
normal animals. In dorsal horn WDR neurons, the extent
of descending facilitation is greater for neurons receiving
a greater C-nociceptor drive, consistent with our pre-
vious findings that COX-1 inhibition had much greater
effects on noxiousC-nociceptorwithdrawal reflexes (Leith
et al. 2007). By contrast, the temperature encoding in
response to A- and C-nociceptive inputs was differentially
modulated by this descending system.
Spinal processing of A- vs. C-fibre nociceptive
information
Not all deep dorsal horn neurons receive C-nociceptor
drive – reports suggest that 51–88%ofdorsal hornneurons
are C+ve depending on species (rat and cat, lower end of
range from cat; Gregor & Zimmermann, 1972; Menetrey
et al. 1977; Waters & Lumb, 2008). Cells in deep laminae
receive C-nociceptor input either indirectly through inter-
neurons in lamina I (which were not studied here), or
directly through WDR dendrites extending into super-
ficial laminae. We found 26/27 neurons to be C+ve, but
stimulation site (percutaneous vs. nerve trunk) and search
stimulus (pinch vs.heat)may account for thesedifferences.
Our descriptions of the response characteristics of dorsal
horn neurons to C- vs. A-nociceptor activation are
consistent with those of dorsal horn WDR neurons and
primary afferents reported elsewhere (Adriaensen et al.
1983; Handwerker et al. 1991; Tillman et al. 1995a,b;
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Figure 3. COX-1 inhibition in the VL-PAG results in a significant increase in firing thresholds to both C-
and A-nociceptor activation
A, digitised traces of raw data displaying responses of a moderate C+ve neuron to C-nociceptor activation, before
and after administration of SC-560 into the VL-PAG. B, SC-560 administration into the VL-PAG resulted in an
increase in response threshold of dorsal horn neurons to C-nociceptor activation compared to vehicle. C, digitised
traces of raw data displaying responses of a moderate C+ve neuron to A–nociceptor activation, before and after
administration of SC-560 into the VL-PAG. D, SC-560 administration into the VL-PAG resulted in an increase in
response threshold of dorsal horn neurons to A-nociceptor activation compared to vehicle. Data are mean ± SEM.
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001, two-way ANOVA plus post hoc Bonferroni tests.
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Yeomans & Proudfit, 1996; Treede et al. 1998; McMullan
& Lumb, 2006b), in that (a) C+ve WDR neurons are
driven by both fast and slow ramps, and (b) the evoked
firing patterns and temperature encoding properties are
distinct and different. A-nociceptors show steep, linear
temperature–response relationships with greater over-
all firing rates, whereas C-nociceptors exhibit more
Gaussian temperature–response relationships, with lower
total responses, that plateau at higher stimulus intensities
(Garell et al. 1996; Andrew & Greenspan, 1999; Slugg
et al. 2000). The plateau in dorsal horn neuronal encoding
of C-nociceptor input could possibly be attributed to
peripheral desensitisation of TRPV1 in the afferents
activated during the stimulus (McMullan et al. 2004;
Joseph et al. 2013), and similar patterns in mechanical
(as opposed to thermal) stimulus encoding properties
have also been reported in mechanoheat-responsive
C-nociceptors (Slugg et al. 2000). This implies that
these encoding functions are inherent properties of the
peripheral nociceptors rather than an artefact of the
stimulation protocol. These findings indicate that A-fibre
nociceptors encode spatial and intensity components
of noxious stimulation more accurately than C-fibre
nociceptors. That the same response properties are
observed in nociceptive afferents and dorsal horn neurons
indicates that the temporal patterns of information
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Figure 4. PAG administration of SC-560 results in a significant change in firing thresholds of both A-
and C-nociceptors
The level of threshold change produced by PAG SC-560 was not significantly different between A- and
C-nociceptors, and was significantly correlated with the degree of C-nociceptor input to the cells. A, peak change
in firing thresholds to A- and C-nociceptor activation produced by SC-560 and vehicle administration into the
VL-PAG. B, correlation between peak threshold change and the magnitude of C-nociceptor input to each cell
evoked by electrical stimulation at 3 times C-fibre threshold (r = 0.6, n = 14, P = 0.03, Spearman’s correlation).
C, overall change with time (AUC) of firing thresholds to A- and C-nociceptor activation produced by SC-560
and vehicle administration into the VL-PAG. D, correlation between overall threshold change with time and the
magnitude of C-nociceptor input to each cell evoked by electrical stimulation at 3 times C-fibre threshold (r = 0.7,
n = 14, P = 0.007, Spearman’s correlation). ∗P < 0.05; n.s., not significant by one-way ANOVA plus Bonferroni
post hoc tests.
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transmitted to higher centres may remain highly distinct
and are dependent on the fibre types activated by the peri-
pheral stimulus.
Differential descending control of spinal A- and
C-nociceptive processing by COX-1-sensitive
mechanisms in the PAG
Inhibition of COX-1 and disruption of descending
facilitation from the VL-PAG produced complex anti-
nociceptive effects on neuronal activity in the dorsal
horn. Loss of descending facilitation affected overall
responses to both A- and C-nociceptor stimulation,
which were increased to a similar extent in individual
C+ve WDR deep dorsal horn neurons and remained
elevated over a similar time course. This is consistent
with our previous study (McMullan & Lumb, 2006a),
in which non-specific activation of the DL-PAG was
used. Similarly, non-selective COX inhibition in the
PAG depressed deep dorsal horn neuronal activity to
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Figure 5. Temperature encoding of A-nociceptor information is maintained in the face of loss of
prostanergic descending control from the PAG following SC-560 administration, whereas encoding
of C-nociceptor information is lost
A, temperature–response relationships to A-nociceptor (, n = 10; and , n = 16) and C-nociceptor (◦,
n = 9; and •, n = 14) rates of skin heating, showing that the ability of cells to encode temperature
is significantly different between fast and slow heat ramp-evoked responses under normal circumstances.
Raw unit activity expressed as mean ± SEM is shown with linear and non-linear (Gaussian) regression lines
modelling A-nociceptor- and C-nociceptor-evoked activity, respectively. B, normalised temperature–response
relationships to A-nociceptor activation before and after SC-560 administration into the VL-PAG. C, normalised
temperature–response relationships to C-nociceptor activation before and after SC-560 administration into the
VL-PAG. The encoding functions denoted by the non-linear regression lines for C-nociceptors were significantly
different after intra-VL-PAG injection (P < 0.0001, F test), whereas the A-nociceptor encoding function was
unchanged (P = 0.32, F test). Data are expressed as mean ± SEM, with the regression lines for the data also
shown. Note that in B the individual regression lines are shown although the comparison of the data shows that
a single linear regression line fits both data sets, i.e. there is no difference between the data sets before and after
SC-560. Individual points are also shown where significantly different between conditions. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001; two-way ANOVA followed by Bonferroni post hoc test. A-nociceptors: effect of drug F1,226 = 4.6,
P = 0.03, effect of temperature relative to threshold F10,226 = 8, P< 0.0001, no interaction F10,226 = 0.4, P = 0.9.
C-nociceptors: effect of drug F1,195 = 84.3, P < 0.0001, effect of temperature relative to threshold F10,195 = 2.3,
P = 0.01, no interaction F10,195 = 1.2, P = 0.3.
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electrical C-fibre stimulation and noxious pinch (a
stimulus likely to co-activate A- and C-fibres; Carlsson &
Jurna, 1987; Vanegas et al. 1997). The pharmacological
inhibition of COX-1 is known to allow diversion of
arachidonic acid metabolism to other pathways, and thus
lead to the production of other lipid mediators. Our
findings might therefore reflect an increase in hydro-
peroxyeicosatetraenoic acid and leukotrienes, lipoxins or
endocanabinoids (Bari et al. 2011), some of which are
known to exert anti-nociceptive effects in thePAG(Palazzo
et al. 2008; de Novellis et al. 2012), rather than a decrease
of a tonic cyclooxygenase activity.
Theprevailing view is that thePAGexerts indiscriminate
modulatory effects on nociceptor-evoked responses in
spinal dorsal horn neurons. Here, we show that the
VL-PAG has the capacity to exert a highly selective tonic
prostanergic facilitation of C+ve dorsal horn neurons,
in the normal animal. This is manifest in two ways:
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Figure 6. Rostrocaudal site of injection of SC-560 within the
PAG does not influence the degree of inhibition of A- or
C-nociceptor-evoked responses
A, injection sites within the VL-PAG: sites of SC-560 injection tested
on slow ramps only (•), fast only (), or both (); vehicle sites tested
on both fast and slow heat ramps (); coordinates are relative to
Bregma (DM, dorsomedial; DL, dorsolateral; L, lateral; VL,
ventrolateral). B, there was no correlation between the rostrocaudal
location of the injection sites within the PAG and the overall change
over time (AUC) in neuronal firing thresholds to A- and C-nociceptor
activation produced by intra-VL-PAG injection of SC-560 (r = 0.23,
n = 19, P = 0.33; Spearman’s correlation) or vehicle (r = −0.3,
n = 12, P = 0.2). Note that some injection sites are overlapping.
first, strongly C+ve neurons are subject to greater
levels of descending control than weak C+ve neurons.
This is the case whether such control is facilitatory or
inhibitory, as we have also shown with non-specific
chemical activation of the PAG where responses of WDR
neurons with both A- and C-fibre inputs (C+ves) were
inhibited, whereas neurons with A-fibre drive alone
(C-ves) were facilitated (Waters & Lumb, 2008). Secondly,
in contrast to the relatively non-selective effects of
COX-1 inhibition in the PAG on A- and C-nociceptor
thresholds, the temperature-response functions of these
different nociceptor groups were differentially modulated
by loss of facilitation from the VL-PAG. This is likely
to be a distinct effect on C-nociceptor inputs rather
than an effect on neurons with greater overall input,
as the effect on dorsal horn encoding properties was
clearly limited to C-nociceptor responses with no effect
on those driven by A-nociceptors (Fig. 5). The results
of the current study provide further insights into the
balances of descending control mechanisms that underlie
the differential modulation of A- and C-nociceptor inputs
into the spinal cord (Vanegas & Schaible, 2004). We can
draw no conclusions relating to the descending controls
on C-ve neurons due to the small number identified in
this study. However, given the relationship between the
magnitude of facilitatory effect and C-fibre drive, they
would be predicted to be unaffected or possibly facilitated
by intra-VL-PAG inhibition of COX-1, as also suggested
by the findings of Waters and Lumb (2008).
Our current findings together with our previous studies
(McMullan & Lumb, 2006b; Waters & Lumb, 2008)
point to a complex interaction of descending modulatory
pathways with spinal neurons, which are likely to inter-
act on multisynaptic spinal pathways postsynaptic to the
primary afferent terminals (thereby inhibiting both A-
andC-fibre afferent input similarly) but presynaptic to the
deep dorsal horn neurons studied (leaving spontaneous,
and presumably also low threshold, inputs unaffected)
(Waters & Lumb, 1997).
Functional significance
The anti-nociceptive effect observed following
COX-1-dependent loss of descending facilitation
indicates that COX-1 is tonically active in the VL-PAG
in the normal animal, and that this pathway targets the
processing of nociceptive input to lamina IV–V WDR
neurons. The rise in response threshold was greatest on
dorsal horn neurons with strong C-fibre drive, suggesting
that these neurons, which are key to the process of
central sensitisation and the establishment of chronic
pain (Treede & Magerl, 2000), are subject to significant
descending facilitation under normal circumstances.
Inhibition of a tonic prostanergic descending facilitation
on C+ve neurons would remove the ability to encode the
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dull, diffuse input deriving from C-nociceptor activation
while accurate information on the intensity and the rate
of rise of the thermal stimulus derived from A-nociceptor
activation would remain intact (see also McMullan
& Lumb, 2006b).
These data indicate that COX activity in the PAG has
an important role in regulating nociceptive processing,
setting the gain at the spinal sensory neuronal level, by
determining the excitability of dorsal horn neurons to
incoming information and balancing the level of A- vs.
C-nociceptive input transmitted to higher centres. End-
ogenous prostanergic descending control from the PAG
could effectively modulate contrast within the cord, as
changes in the strength of the pathway would sharpen
some inputs and damp down others through the targeting
of different populations of neurons that encode incoming
information.
We speculate that, physiologically, this fine balance
of descending control over A- vs. C-nociceptors might
be rapidly altered in different behavioural states and, in
so doing, forward information that triggers appropriate,
and co-ordinated, behavioural, affective and autonomic
responses. For instance, we speculate that decreasing
the level of descending facilitation from the PAG would
decrease the level of nociceptive information originating
from C-fibre afferents from reaching higher structures
(distracting information that might impede survival)
while maintaining the transmission of rapidly conducted
A-fibre-mediated inputs. The latter is predicted to provide
a protective function in driving withdrawal responses
and directing motivational behaviours that aid survival
(e.g. Waters & Lumb, 2008). Additionally, use of centrally
penetrant COX inhibitors in acute pain might be
expected to have some effect on the more debilitating
C-nociceptor-evoked pain.
In addition to their different roles in acute nociceptive
processing (slow vs. fast pain), C- and A-nociceptor
sub-types play distinct roles in chronic pain states (Fuchs
et al. 2000; Magerl et al. 2001; You et al. 2010). It
is apparent that pathological alterations in descending
controls contribute to the development and maintenance
of chronic pain states (Porreca et al. 2002; Vanegas
& Schaible, 2004; Geranton et al. 2008; Hu et al. 2009),
and that these involve intra-PAG prostaglandins (Palazzo
et al. 2011), and so, as previously suggested (You et al.
2010), an understanding of the mechanisms underlying
the preferential control of these distinct inputs is both
clinically relevant and important.
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